• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Veterinarian charged with plot to drug horses before races

March 7, 2017

Kyle James Hebert allegedly schemed to influence race outcomes by doping horses with frog juice.

A Louisiana veterinarian has been charged with engaging in a scheme to influence the outcome of horse races by illegally treating the animals with a synthetic version of a drug known as “frog juice,” according to a recent news report from the Associated Press.

According to the report, the federal indictment accuses the veterinarian, Kyle James Hebert, DVM, of providing trainers with syringes of dermorphin, an opioid roughly 30 times more potent than morphine that is naturally secreted by tree frogs native to South America, to inject the painkiller in at least four horses that compete at Louisiana racetracks. The indictment, returned February 9 by a grand jury in the Western District of Louisiana, says Hebert told trainers that the mislabeled drug would make the horses “focus” and run faster.

The report notes that the U.S. Food and Drug Administration hasn't approved any drug containing dermorphin for use in humans or animals.

Hebert's practice, Southern Equine Sports Medicine, operates veterinary clinics in Lake Charles and Sunset in the state of Louisiana. The indictment charges him and an Omaha, Nebraska-based company, Kohll's Pharmacy & Healthcare Inc., with conspiracy, according to the AP report.

Hebert is licensed to practice veterinary medicine at racetracks by the Louisiana State Racing Commission. In 2012, the commission sanctioned nine trainers whose horses tested positive for dermorphin, according to the report.

The indictment says Hebert purchased approximately $25,000 worth of the mislabeled drug from Kohll's between November 2010 and May 2012. Kohll's invoices falsely identified the drug as “d-peptide,” a fictitious name, according to the indictment.

One of the sanctioned trainers told the commission that Hebert gave drugs to his horses and had claimed they were “human herbs that would boost metabolism and help them breathe a bit,” according to a Times-Picayune report in September of that year.

Advertisement

Charles Gardiner, the commission's executive director, says he believes the indictment secured by U.S. Attorney Stephanie Finley's office marks the first criminal charges over the use of dermorphin at Louisiana racetracks. Gardiner says 11 horses linked to the nine trainers tested positive for the drug. He calls it “the most serious offenses in the history of Louisiana racing,” according to the report.

“It endangered the horses, it affected the outcome of races and it defrauded the wagering public,” Gardiner says in the report.

Hebert is accused of falsifying invoices for his veterinary services to conceal that the drugs were provided to trainers on race days, according to the report. Racing commission regulations prohibit anyone from injecting any substance into a horse within four hours of a race. The indictment says Hebert and his employees instructed trainers to perform injections one hour before race time.

Steven Barker, PhD, MVSc, a professor emeritus from Louisiana State University's School of Veterinary Medicine, oversaw lab tests for dermorphin on samples collected from racing regulators in both Louisiana and Oklahoma, the report states.

Barker says the use and concealment of performance-enhancing drugs has always been a “cat and mouse game” in the horse racing industry. But its rate of positive drug tests is low compared to “human athletic endeavors,” he says in the report.

“The actual number of cases where there appears to be an obvious attempt to gain an advantage is very small, Barker says in the report. 

Related Content:

Law & EthicsEquine MedicineBreaking NewsEquine
Updates on state legislation for veterinary virtual care
Updates on state legislation for veterinary virtual care
PARI acquires Nortev, manufacturer of an equine respiratory therapy device
PARI acquires Nortev, manufacturer of an equine respiratory therapy device
Battling the equine sarcoid
Battling the equine sarcoid

Advertisement

Latest News

Drug for acute onset of canine pancreatitis is launched on the US market

New Automatic 2-in-1 Pet Feeder and Water Dispenser launched

PetHub launches AI tools for pet owners

Prairie dog pups emerge from underground at Maryland Zoo

View More Latest News
Advertisement